# A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

> **NCT05642312** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 245 (actual)

## Conditions studied

- Uveitic Macular Edema

## Interventions

- **DRUG:** Vamikibart
- **OTHER:** Sham

## Key facts

- **NCT ID:** NCT05642312
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-09
- **Primary completion:** 2024-12-09
- **Final completion:** 2025-07-09
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642312, "A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05642312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*